LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
LKFT
77 hedge funds and large institutions have $932M invested in Lakefront Biotherapeutics American Depositary Shares in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.32% less ownership
Funds ownership: 19.83% → 19.51% (-0.32%)
9% less capital invested
Capital invested by funds: $1.03B → $932M (-$95.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
77
Holding in Top 10
–
Calls
$634K
Puts
$564K
Top Buyers
| 1 | +$18.6M | |
| 2 | +$6.05M | |
| 3 | +$5.97M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$5.09M |
| 5 |
Millennium Management
New York
|
+$4.29M |
Top Sellers
| 1 | -$27.6M | |
| 2 | -$12.3M | |
| 3 | -$7.03M | |
| 4 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$4.28M |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$3.9M |